| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 48,929 | 69,695 | 55,027 | | Cost of Revenue | 3,553 | 3,599 | 3,538 | | | Gross Profit | 45,375 | 66,096 | 51,489 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 393 | 422 | 446 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 44,982 | 65,674 | 51,043 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (83,821) | (29,432) | (22,453) | | Earnings Before Interest And Taxes | 44,982 | 39,000 | 31,657 | | Interest Expense | 6,164 | 16,545 | 7,427 | | Income Before Tax | 38,818 | 22,455 | 24,230 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (45,004) | 19,697 | 21,163 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (45,004) | 19,697 | 21,163 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($45,004) | $19,697 | $21,163 |
|
0.83% Nasdaq 
Income Statement
